NO20074949L - Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav - Google Patents

Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav

Info

Publication number
NO20074949L
NO20074949L NO20074949A NO20074949A NO20074949L NO 20074949 L NO20074949 L NO 20074949L NO 20074949 A NO20074949 A NO 20074949A NO 20074949 A NO20074949 A NO 20074949A NO 20074949 L NO20074949 L NO 20074949L
Authority
NO
Norway
Prior art keywords
preparation
fish
treatment
administered orally
specified
Prior art date
Application number
NO20074949A
Other languages
English (en)
Norwegian (no)
Inventor
Malte Adelmann
Dieter Fichtner
Bodo Lange
Werner Weitschies
Original Assignee
Riemser Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riemser Arzneimittel Ag filed Critical Riemser Arzneimittel Ag
Publication of NO20074949L publication Critical patent/NO20074949L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Farming Of Fish And Shellfish (AREA)
NO20074949A 2005-03-02 2007-10-01 Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav NO20074949L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005010288A DE102005010288A1 (de) 2005-03-02 2005-03-02 Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
PCT/EP2005/013497 WO2006092168A1 (de) 2005-03-02 2005-12-13 Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung

Publications (1)

Publication Number Publication Date
NO20074949L true NO20074949L (no) 2007-11-28

Family

ID=36013614

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074949A NO20074949L (no) 2005-03-02 2007-10-01 Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav

Country Status (14)

Country Link
US (1) US8414947B2 (pl)
EP (1) EP1853308B1 (pl)
JP (1) JP4903166B2 (pl)
CN (1) CN101141978B (pl)
AT (1) ATE547117T1 (pl)
CA (1) CA2599831C (pl)
DE (1) DE102005010288A1 (pl)
DK (1) DK1853308T3 (pl)
ES (1) ES2382553T3 (pl)
NO (1) NO20074949L (pl)
PL (1) PL1853308T3 (pl)
SI (1) SI1853308T1 (pl)
WO (1) WO2006092168A1 (pl)
ZA (1) ZA200707193B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101322228B1 (ko) * 2012-05-04 2013-10-28 대한민국 넙치의 바이러스성 출혈성 패혈증 예방용 백신
CN105797149A (zh) * 2016-04-21 2016-07-27 中国水产科学研究院珠江水产研究所 草鱼细菌性败血症和草鱼细菌性赤皮病二联蜂胶灭活疫苗及制备工艺
WO2023183471A1 (en) * 2022-03-24 2023-09-28 Dutch Creek Nymphing, Llc Composition and method of applying same to increase survival of fish following catch-and-release situations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388565B (de) * 1987-12-02 1989-07-25 Koelbl Oskar Verfahren zur vermehrung des erregers der viralen haemorrhagischen septikaemie (vhs) der forellen in warmblueterzellkulturen
WO1999050419A2 (en) * 1998-03-31 1999-10-07 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
NZ520238A (en) * 2000-01-27 2004-04-30 Peros Systemes Technologies In Composition for intestinal delivery
WO2003086097A1 (en) 2002-04-08 2003-10-23 Peros Systèmes Technologies Inc. Composition for modulating a physiological reaction or inducing an immune response
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
JP4150631B2 (ja) * 2003-05-30 2008-09-17 川崎三鷹製薬株式会社 魚類冷水病ワクチン

Also Published As

Publication number Publication date
JP4903166B2 (ja) 2012-03-28
CA2599831C (en) 2014-09-23
ZA200707193B (en) 2008-07-30
DK1853308T3 (da) 2012-06-25
EP1853308A1 (de) 2007-11-14
CN101141978A (zh) 2008-03-12
ES2382553T3 (es) 2012-06-11
PL1853308T3 (pl) 2012-09-28
CN101141978B (zh) 2012-06-13
DE102005010288A1 (de) 2006-09-07
US8414947B2 (en) 2013-04-09
JP2008531610A (ja) 2008-08-14
CA2599831A1 (en) 2006-09-08
WO2006092168A1 (de) 2006-09-08
US20080317825A1 (en) 2008-12-25
SI1853308T1 (sl) 2012-07-31
ATE547117T1 (de) 2012-03-15
EP1853308B1 (de) 2012-02-29

Similar Documents

Publication Publication Date Title
ATE430154T1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
UY32599A (es) Formulación oral sólida de abt-263
WO2003077828A3 (en) Novel florfenicol-type antibiotics
JP2009526751A5 (pl)
CY1118179T1 (el) Φαρμακευτικη συνθεση
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
JP2010529118A5 (pl)
FI3457135T3 (fi) Fabryn taudin hoitovaihtoehtoja
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
WO2008064299A3 (en) Methods of reducing porcine circovirus-associated disease outbreaks
Saini et al. Periodontal diseases: a risk factor to cardiovascular disease
WO2008017826A3 (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
CY1120240T1 (el) Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
CL2021000160A1 (es) Forma de dosificación farmacéutica administrable por vía oral con liberación modificada
JP2010511039A5 (pl)
NO20074949L (no) Farmasoytisk preparat som kan administreres oralt for behandling av fisk, fremstillingsmetode for angitte preparat og anvendelse derav
WO2005005481A3 (en) Combination therapy for gastroenteric diseases caused by microorganisms
NO20054180D0 (no) Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner
JP2009505991A5 (pl)
SE0401631D0 (sv) New Composition
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
DE502005007472D1 (de) Desoxo-nonadepsipeptide

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: RIEMSER PHARMA GMBH, DE

FC2A Withdrawal, rejection or dismissal of laid open patent application